Marvell Technology (MRVL) reported a significant increase in its data center division's first-quarter revenue, but this did not offset declines in other segments. The company warned in March that sales figures would likely disappoint, but said that its non-data center divisions should recover in the second half of the year. The total revenue for the quarter was $1.16 billion, narrowly above the $1.15 billion analysts expected due to strong demand for its artificial intelligence-related products.
Marvell (MRVL) reported a wider-than-expected loss of $215.6 million, or 25 cents per share, as analyst estimates projected a quarterly loss of $196.6 million, or 20 cents per share. Last year, the company lost $168.9 million, or 20 cents per share, in the first quarter.
Marvel's (MRVL) 87% jump in data center revenue to $816.4 million, largely fueled by its AI-related products, wasn't enough to offset declines in its other divisions, which ranged from 13% to 75% compared with last year. The company warned in March that the quarter's results would likely disappoint, but said the declines should be limited to the first quarter as businesses recover in the second half of the year.
Jefferies analysts raised their price target for Marvell stock (MRVL) to $90 from $85, writing that recovery in the company's other divisions "should start to recover and layer on top of the AI business that currently acts as the primary driver of the stock." Marvell projects revenue within 5% of $1.25 billion for the current quarter, with a loss per share of 15 cents to 25 cents.
Technical Outlook Marvell (MRVL) stock is down 11.16% at $68.11 as of the time of writing trading below the 100- day Close Moving Average. The daily price chart shows a long Bearish Harami candle stick pattern which is a bearish reversal pattern. The Relative Strength Index (RSI) however, remains strong moving steadily giving hopes for buyers to delve in.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.